Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Stephen A HarrisonJohn M Vierling

Abstract

Patients with chronic hepatitis C and insulin resistance are less likely to respond to anti-hepatitis C virus (HCV) therapy and are at risk for more rapid fibrosis progression. Coadministration of pioglitazone with peginterferon/ribavirin improves insulin sensitivity and increases virologic response rates in insulin-resistant HCV genotype 4 patients, but it is unclear whether this finding applies to genotype 1 patients. For this reason we randomized treatment-naive HCV genotype 1 patients with insulin resistance to receive either standard care (peginterferon alpha-2a plus ribavirin for 48 weeks, n = 73) or pioglitazone 30-45 mg/day plus standard care (n = 77) in an open-label multicenter trial. Patients randomized to pioglitazone received the drug during a 16-week run-in phase, the 48-week standard-care phase, and the 24-week untreated follow-up phase. Pioglitazone treatment improved hemoglobin A1c (HbA1c), plasma glucose, insulin levels, and homeostasis model assessment of insulin resistance score and increased serum adiponectin levels during the 16-week run-in phase and maintained these improvements during the standard-care phase. However, we observed no statistically significant difference between the two groups in the prima...Continue Reading

References

Mar 1, 1995·Diabetic Medicine : a Journal of the British Diabetic Association·H GrayS O'Rahilly
Jan 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A L MasonR P Perrillo
Aug 14, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·I BalikH Yasa
Aug 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·G GongA Siddiqui
Jun 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Thierry PoynardJanice Albrecht
Apr 22, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stephen A Harrison
Dec 26, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hari S ConjeevaramUNKNOWN Virahep-C Study Group
Apr 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Valerio PazienzaFrancesco Negro
Nov 22, 2007·Liver International : Official Journal of the International Association for the Study of the Liver·Ching-Sheng HsuDing-Shinn Chen
Jan 15, 2008·The American Journal of Gastroenterology·Theodoros A ZografosGeorge N Dalekos
Jun 17, 2008·Journal of Hepatology·Kathrin OverbeckUNKNOWN Swiss Association for the Study of the Liver (SASL)
Aug 12, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Amalia GastaldelliKenneth Cusi
Oct 22, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Manuel Romero-GómezUNKNOWN Spanish Treatment of Resistance to Insulin in Hepatitis C Genotype 1 Group
Nov 19, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Mahmoud KhattabLamia Hamdy
Feb 17, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Aymin Delgado-BorregoUNKNOWN Halt-C Trial Group
Mar 18, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josephine H LiJeanette J McCarthy
Jul 29, 2010·Alimentary Pharmacology & Therapeutics·A GastaldelliK Cusi
Aug 18, 2010·Clinical and Experimental Medicine·Hatem Abdel LatifWafaa I Rasheed
Jan 22, 2011·Gut·Mohammed EslamStephen A Harrison
Mar 30, 2011·Alimentary Pharmacology & Therapeutics·G FattovichUNKNOWN ITAHEC Study Group
Aug 30, 2011·Gut·Alexander J ThompsonUNKNOWN ACHIEVE-1 and ACHIEVE-2/3 Study Teams

❮ Previous
Next ❯

Citations

Jun 16, 2012·International Journal of Hepatology·Munechika EnjojiMakoto Nakamuta
Nov 14, 2013·World Journal of Gastroenterology : WJG·Alessandro GrassoRoberto Testa
Mar 25, 2014·World Journal of Gastroenterology : WJG·Yasunori Kawaguchi, Toshihiko Mizuta
Nov 28, 2013·Antiviral Research·Steven J CoatsRaymond F Schinazi
Jan 29, 2014·Antiviral Research·Christopher Koh, T Jake Liang
Mar 14, 2014·Journal of Medicinal Chemistry·Makonen BelemaNicholas A Meanwell
Mar 4, 2014·Hepatology International·Alessandra Mangia, Maria Ripoli
Aug 30, 2012·Expert Review of Gastroenterology & Hepatology·Stephen A HarrisonKatharine K Roberts
Dec 8, 2015·Expert Review of Gastroenterology & Hepatology·Paola DongiovanniLuca Valenti
May 4, 2013·Expert Review of Gastroenterology & Hepatology·Ludovico Abenavoli, Samir Rouabhia
Mar 29, 2014·Expert Opinion on Drug Metabolism & Toxicology·André J Scheen
Oct 16, 2015·Digestive Diseases and Sciences·Diego García-CompeánHéctor J Maldonado-Garza
Nov 28, 2013·Clinics in Liver Disease·Nicolas Goossens, Francesco Negro
Sep 1, 2015·Gastroenterology·Francesco NegroMichael P Manns
Jan 18, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chia-Hsuin ChangLee-Ming Chuang
Jun 11, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kenneth Cusi
Jan 15, 2015·Journal of Medical Virology·Ekram W Abd El-WahabHanan Z Shatat
Aug 6, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Manuel Romero-Gómez, José A Del Campo
Dec 18, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Paulino Tallón de LaraFrancesco Negro
Jan 3, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair YounossiJames Witek
Dec 18, 2013·Journal of Hepatology·UNKNOWN European Association for Study of Liver
Jun 10, 2014·Journal of Gastroenterology and Hepatology·Naohiko MasakiMasashi Mizokami
Dec 29, 2016·World Journal of Gastroenterology : WJG·Mark R PedersenAnil B Seetharam
Jan 26, 2016·World Journal of Hepatology·Hilla Knobler, Stephen Malnick
Mar 23, 2017·World Journal of Gastroenterology : WJG·Anne-Claire Desbois, Patrice Cacoub
Feb 13, 2019·European Journal of Pharmacology·Milad IranshahyGholamreza Karimi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.